SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001127602-24-016031
Filing Date
2024-05-20
Accepted
2024-05-20 17:53:48
Documents
1
Period of Report
2024-05-17

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form4a.html 4/A  
1 PRIMARY DOCUMENT form4a.xml 4/A 3387
  Complete submission text file 0001127602-24-016031.txt   5189
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Bausch Health Companies Inc. (Issuer) CIK: 0000885590 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O ICAHN CAPITAL LP 767 FIFTH AVENUE, SUITE 4700 NEW YORK NY 10153
Business Address
Mulligan Richard (Reporting) CIK: 0001376247 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-14956 | Film No.: 24966241